IndraLab

Statements

Hydroxychloroquine activates Emactuzumab. 1 / 1

| 1

reach

"Emactuzumab was discontinued and both patients were treated with hydroxychloroquine associated with low-dose steroid, which led to rapid clinical improvement."

26179200

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Hydroxychloroquine activates Emactuzumab. 1 / 1

INDRA sources:

Databases

Reading